Trials / Terminated
TerminatedNCT03530449
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Heidelberg Engineering GmbH · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS
Detailed description
The objectives of this study are to: 1. Assess the repeatability and reproducibility of the SPECTRALIS with OCTA Module image quality 2. Assess the repeatability and reproducibility of visibility of key anatomical vascular structures in the SPECTRALIS with OCTA Module
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCT Angiography | OCT Angiography offers clinicians a non-invasive three-dimensional visualization of vasculature in the retina and choroid. The visualization of perfused vasculature in a three-dimensional layout, offers clinicians an aid in the identification of retinal and choroidal pathologies such as retinal ischemia, microaneurysms, retinal neovascularization and choroidal neovascular membranes. |
| DEVICE | Color Fundus Photography | Non-contact white light photography |
| DEVICE | Optical Coherence Tomography | Two and Three dimensional cross sectional imaging of the back of the eye to look at vascular structures and is an aid in the detection and management of various ocular diseases. |
Timeline
- Start date
- 2018-04-30
- Primary completion
- 2018-09-15
- Completion
- 2018-09-15
- First posted
- 2018-05-21
- Last updated
- 2019-02-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03530449. Inclusion in this directory is not an endorsement.